Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
60.98
-0.57 (-0.93%)
At close: Sep 18, 2026, 4:00 PM EDT
60.59
-0.39 (-0.64%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $602.76 million as of September 18, 2026. Its market cap has increased by 72.79% in one year.
Market Cap
602.76M
Enterprise Value
382.80M
1-Year Change
72.79%
Ranking
Category
Stock Price
$60.98
ChartMarket Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $602.76M, an increase of 1,342.58%. That is a compound annual growth rate of 60.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 602.76M | -3.89% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oculis Holding AG | 625.96M |
| Scribe Therapeutics | 624.75M |
| Valneva SE | 608.96M |
| MapLight Therapeutics | 606.89M |
| Shattuck Labs | 603.18M |
| CorMedix | 601.73M |
| CytomX Therapeutics | 601.40M |
| AgomAb Therapeutics NV | 599.35M |